RT Journal Article
SR Electronic
T1 Hypertension diagnosis, treatment, and control in India: nationally representative results from 1.69 million adults, 2019-2021
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.06.02.23290909
DO 10.1101/2023.06.02.23290909
A1 Varghese, Jithin Sam
A1 Venkateshmurthy, Nikhil Srinivasapura
A1 Sudharsanan, Nikkil
A1 Jeemon, Panniyammakal
A1 Patel, Shivani A
A1 Thirumurthy, Harsha
A1 Roy, Ambuj
A1 Tandon, Nikhil
A1 Narayan, KM Venkat
A1 Prabhakaran, Dorairaj
A1 Ali, Mohammed K.
YR 2023
UL http://medrxiv.org/content/early/2023/06/05/2023.06.02.23290909.abstract
AB Background Hypertension is a major cause of morbidity and mortality worldwide. Previous efforts to characterize gaps in the hypertension care continuum in India –including diagnosis, treatment, and control– did not assess district level variation. Local data are critical for planning, implementation, and monitoring efforts to curb hypertension burdens. Our objective is to characterize the hypertension care continuum in India among individuals aged 18-98 years old at national, state, and district levels and by socio-demographic group.Methods Data were from 1,895,297 individuals in the nationally representative Fifth National Family Health Survey (NFHS-5), 2019-21. Hypertension was defined as self-reported diagnosis or newly measured blood pressure ≥140/90 mmHg. Among those with hypertension, we calculated the proportion diagnosed (self-reported). Among those with diagnosed hypertension, we computed the proportion treated (self-reported medication use). Among those treated, we calculated the proportion controlled (BP <140/90 mmHg [20-80 years] or <150/90 mmHg [>80 years]) based on national guidelines. Estimates were also provided among the total with hypertension. To assess differences in the care continuum between or within states (i.e. between districts), we partitioned the variance at both levels using linear mixed models.Results Among 1,691,109 adult respondents nationally (52.6% female; mean age: 41.6 years), 28.2% [95%CI: 28.0-28.4] had hypertension, of whom, 36.7% [36.3-37.2] were diagnosed. Among those diagnosed, 44.7% [44.1-45.3] reported taking medication (17.7% [17.5-17.9] of total with hypertension). Among those treated, 52.3% [51.4-53.1] had blood pressure control (9.1% [8.9-9.2] of total with hypertension). There were substantial variations across districts in diagnosis [range: 6.3–77.5%], treatment [8.7–97.1%] and control [2.7–76.6%]. Notably, large proportions of the variation in hypertension diagnosis (53.7%), treatment (32.8%), and control (57.7%) were within states, not just between states.Conclusions In India, more than 1 in 4 people have hypertension, and of these, only 1 in 3 are diagnosed, less than 1 in 5 are treated, and only 1 in 11 controlled. National averages hide considerable state- and district-level variation in the care continuum, implying the need for targeted, decentralized solutions to improve the hypertension care continuum in India.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot ApplicableFunding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All participants gave written informed consent before participation. We were exempted from ethical approval for the secondary data analysis from the Institutional Review Board of Emory University.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll datasets used in this analysis are available for download at www.dhsprogram.com. The code for the analysis is available on https://github.com/jvargh7/hypertension_cascade. https://github.com/jvargh7/hypertension_cascade https://dhsprogram.com/ ICMRIndian Council of Medical ResearchLASILongitudinal Aging Study in IndiaNFHSNational Family Health SurveysNNMSNational Noncommunicable Disease Monitoring SurveyUTUnion TerritoryWHOWorld Health Organization